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INTRODUCTION 1
Establishment of the fetal-maternal interface in early pregnancy requires coordinated 2 interactions between fetal and maternal cells that help direct placentation and ensure an adequate blood 3 supply to the developing fetus. Early stages of uterine angiogenesis, arterial remodeling, trophoblast 4 invasion & survival, as well as maternal tolerance toward the fetal semi-allograft are controlled in part 5 by maternally-derived uterine immune cells 1,2 . In particular, uterine natural killer cells (uNK), 6 identifiable as CD56 bright /CD16cells in humans, constitute the most abundant leukocyte population 7 within the uterus accounting for ∼70% of immune cells 2, 3 . Unlike peripheral blood NK cells (pbNK), 8 uNK do not normally mount cytotoxic responses, but instead help coordinate placental development by 9 controlling uterine neo-angiogenesis and spiral artery remodeling, as well as limiting the immune 10 response against fetal antigen 4 . 11 NK activity (i.e. cytotoxicity, cytokine & angiokine production) is controlled in part by 12 activating and inhibiting natural killer receptors (NKRs). NKRs bind epitopes expressed on major 13 histocompatibility (MHC) class I and class I-like molecules, stress-related molecules and cytokines [5] [6] [7] . 14 Generally, signaling via activating receptors stimulate cytolytic programs whereas signaling via 15 inhibitory receptors drives immuno-tolerance through mechanisms that dampen activating NKR signal 16 transduction pathways 8 . uNK are phenotypically distinct from pbNK (pbNK are defined phenotypically 17 as CD56 dim /CD16 + ) in that they express a distinct repertoire of NKRs that facilitate interaction with 18 trophoblast-derived MHC class I molecules (HLA-C, HLA-E, and HLA-G) but not HLA-A or HLA-19 B 9 . Depending on the activating/inhibitory NKR balance, interaction of uNK with MHC ligand can 20 promote or restrain uNK activity. It is suggested that inadequate (not enough) or inappropriate (too 21 much) uNK activation contributes to preterm birth, recurrent miscarriage, and preeclampsia by limiting 22 angiogenesis/artery remodeling or over-sensitizing uNK to being cytotoxic [10] [11] [12] [13] [14] [15] [16] . 23
Obesity, with a prevalence between 13-18% in women of reproductive age 17 , correlates with 1 higher incidences of poor pregnancy outcomes 18, 19 . For example, pre-existing obesity associates with 2 recurrent miscarriage 20 , gestational diabetes 21 , preterm birth 22 , and preeclampsia 23 . Studies designed to 3 generate insight into how maternal obesity contributes to poor pregnancy outcomes have shown in 4 rodents that high-fat diet exposure prior to and during pregnancy results in impaired uterine artery 5 remodeling 24, 25 . Notably, vascular defects of this type are also observed in rats and mice deficient in 6 uNK 26 . Consistent with these observations, previous findings from our group show that maternal 7 obesity in women associates with impaired uterine artery remodeling 27 . Importantly, we show that 8 vascular changes coincide with fewer uNK and altered global uNK gene expression 27 . Together, these 9 studies suggest that obesity may modify pro-angiogenic and vascular-remodeling programs controlled 10 by uNK within the maternal-fetal interface. However, little is known about how maternal obesity 11 affects uNK biology. 12
In this study we examine if maternal obesity alters uNK activity and function. We show that 13 uNK from obese women are more active and secrete different amounts of the angiogenic factors PlGF 14 and VEGF-A. Phenotypic analyses show altered expression of NKRs in obese women compared to 15 lean women, where differences in activating (NKp46, KIR2DS1) and inhibitory (NKG2A, KIR2DL1) 16 NKR cell populations are observed. Importantly, we provide evidence that the increase in obesity-17 linked uNK activity is in part due to changes in expression of the NKRs KIR2DL1 and KIR2DS1. We 18
show that upon HLA-C2 stimulation, KIR2DS1-expressing uNK from lean and obese women 19 differentially regulate TNFα production. Together, this work provides insight into how maternal 20 obesity affects uNK function. Further, this work identifies uNK-directed processes modified in obesity 21 that may contribute to impaired vascular remodeling, placental function and pregnancy outcome. 22
RESULTS 1

Maternal obesity promotes uNK activation 2
Our lab previously reported that maternal obesity associates with reductions in uNK cell 3 numbers and coincides with impaired uterine blood vessel remodeling 27 . To examine if these changes 4 might be linked with altered uNK activity, we compared degranulation/activation responses in uNK 5 isolated from lean (BMI 20-24.9 kg m -2 ) and obese (BMI ≥30 kg m -2 ) women in their first trimester of 6 pregnancy ( Table 1) . Following culture in the presence or absence of phorbol 12-myristate 13-7 acetate/ionomycin (PMA), uNK activity was measured via surface expression of the degranulation 8 marker CD107a 28 . For these studies, uNK were defined as CD56 bright /CD9 + /CD16 -/CD3 -CD45 + cells 9 ( Figure 1a ). As expected, PMA stimulation resulted in potent uNK activation in both BMI groups 10 ( Figure 1b,c) . However, proportions of CD107a + uNK from obese women were more abundant in both 11 unstimulated (median = 5.4% vs 2.6%) and stimulated (median = 11.8% vs 5.9%) conditions ( Figure  12 1c). These initial findings indicate that maternal obesity associates with a heightened state of uNK 13 activation. 14 15 Obesity associates with altered uNK angiokine production 16
To gain insight into how obesity-linked differences in uNK activity translate into uNK 17 functional differences, we measured by flow cytometry the intracellular production of tumor necrosis 18 factor α (TNFα) and interferon gamma (IFNγ), two cytokines expressed by uNK known to play central 19 roles in uterine blood vessel remodeling 29 . In line with higher CD107a + uNK proportions, a non-20 significant but trending increase in baseline TNFα production was observed in uNK from obese women 21 (P = 0.05); baseline IFNγ levels between BMI groups were similar (Figure 2a-c). Following PMA 22 stimulation, uNK from both groups markedly enhanced production of TNFα and IFNγ (Figure 2c ). 23
Although we did not detect a significant difference in cytokine expression between BMI groups, uNK 1 from obese women again showed a slight tendency to produce more TNFα (median = 19.4% vs 9.9%, 2 P = 0.05) ( Figure 2c ). 3
To complement the above intracellular cytokine measurements, we also measured the secretion 4 of 8 factors from conditioned media (CM) generated by uNK-enriched ex vivo cultures (> 60% uNK) 5 from lean and obese women. These factors included: granulocyte-macrophage colony-stimulating 6 factor (GM-CSF), interleukin 10 (IL10), interferon-γ inducible protein 10 (IP10), macrophage 7 inflammatory protein 1β (MIP1β), placental growth factor (PlGF), TNFα, and vascular endothelial 8 growth factor A and C (VEGF-A, VEGF-C). These cytokines were chosen based on prior studies 9
showing their production by uNK and their importance in controlling pregnancy-related processes 30, 31 . 10 uNK CM from obese women secreted lower amounts of VEGF-A (median = 6.8 pg/ml vs 18.4 pg/ml) 11 and higher amounts PlGF (median = 1.0 pg/ml vs 0.3 pg/ml) ( Figure 2d ). However, secretion of TNFα, 12 VEGF-C, GM-CSF, IL10, IP10 and MIP1β were comparable between uNK CM from either BMI 13 group (Figure 2d-f). Our results suggest that obesity-linked changes in uNK activity translate into 14 differences in angiokine secretion, reflecting possible modifications to angiogenic processes. 15
16
Maternal obesity associates with phenotypical differences in NKR expression 17
Our finding that maternal obesity associates with heightened uNK activity and altered angiokine 18 production indicates that differences in NKR expression/abundance may exist. To examine this, we 19 compared the expression of 8 NKRs in uNKs from lean and obese women using a flow cytometry 20 approach outlined in Supplementary Figure 1a . Specifically, we measured activating (NKG2D) and 21 inhibitory (NKG2A) CD94/NKG2 family members, natural cytotoxicity receptors NKp30, NKp44 and 22
NKp46, inhibitory leukocyte immunoglobulin-like receptor (LILRB) 1, and members of the killer-cell 1 immunoglobulin-like receptor (KIR)2D subfamily [using antibodies targeting KIR2DL4 and 2 KIR2D(L1/S1/S3/S5)]. These NKRs were selected in part due to their importance in controlling NK 3 cell activation 5,6,8 , their prior description in uNK 30,32 , or their association with pregnancy-related 4 outcome 16, 33, 34 . uNK from lean women ubiquitously expressed inhibitory NKG2A and activating 5
NKp30 and NKp46, while varied proportions of NKG2D + (58.9%), LILRB1 + (30.1%), and KIR2DL4 + 6 (62.0%) uNK were observed (Figure 3a -d, and S1b-e). Between BMI groups, proportions of NKG2D + , 7
NKp30 + , NKp44 + , LILRB1 + , and KIR2DL4 + uNK were comparable, however, maternal obesity 8 associated with a decrease in NKG2A + (93.3% vs 96.6%) and NKp46 + (68.3% vs 96.0%) cell 9
proportions (Figure 3a 
Maternal obesity drives KIR2DL1/S1 NKR imbalances 19
KIRs are involved in NK cell education, promotion of fetal tolerance and contribution to 20 successful placentation 35, 36 . Because previous studies have highlighted strong associations with 21 pregnancy outcome and KIR2DL1/S1 expression 35 , and because we showed that maternal obesity 22 associates with increased proportions of KIR2D + uNK, we next set out to examine if maternal obesity 23 leads to imbalances in inhibitory KIR2DL1 (2DL1) or activating KIR2DS1 (2DS1). Using a flow 1 cytometry approach that identifies distinct 2DL1 and 2DS1 single-positive (sp) and mixed double-2 positive (dp) uNK populations (Figure 4a ), we measured proportions and surface expression levels of 3 these KIRs in lean and obese women. Analysis by qPCR revealed that maternal obesity correlates with 4 higher mRNA levels of KIR2DS1 in uNK (purified by negative selection), while levels of inhibitory 5 KIR2DL1 and activating KIR2DS3/S5 did not differ between BMI groups (Supplementary Figure S2) . 6
As the presence or absence of 2DS1 depends on inherent maternal and paternal haplotype 7 combinations [two main haplotypes exists: haplotype A (HA), primarily comprised of inhibitory 8 receptors (i.e. lacking 2DS1), and haplotype B (HB), containing both activating and inhibitory 9 receptors, including 2DS1 37 ], we sub-stratified lean and obese cohorts into KIR HB -(2DL1 + /S1 -) and 10 HB + (2DL1 + /S1 + ) by PCR genotyping (Supplemental Table 1 ). Flow cytometry analysis revealed that 11 HB -uNK are negative for 2DS1, whereas mixed 2DL1 + /2DS1 + populations are seen within HB + cells in 12 both lean and obese women (Figure 4a ,b). Among HBindividuals (> 95% are allotypically 2DL1 38 ), 13 total proportions of 2DL1 + uNK were similar between lean and obese women ( Figure 4c ). Interestingly, 14 uNK from obese HB + women showed reduced proportions of 2DL1 + cells (gated on total CD56 bright 15 uNK; median = 23.8% vs 34.5%). In either haplotype, 2DL1 MFI did not differ between lean and obese 16 groups ( Figure 4d ). 17
Focusing on only HB + (containing 2DS1 gene) uNK, we again examined 2DL1/S1 subsets 18 within KIR + cells in both BMI groups. Proportions of 2DS1sp and dp populations did not differ 19 between lean and obese groups ( Figure 4e ). However, 2DS1 surface expression (MFI) within the 20 2DS1sp population in obese women was approximately 2-fold higher; levels of 2DL1 within 21 2DL1/S1dp and 2DL1sp populations did not differ ( Figure 4e ). Measuring 2DS1 MFI on all KIR + uNK 22
(combined 2DS1sp and 2DL1/S1dp populations) showed that, similar to expression within the 2DS1sp 23 population, 2DS1 levels are elevated in uNK from obese women ( Figure 4f ). Together our results 1 indicate that maternal obesity instructs changes in KIR2D expression to preferentially favour 2DS1, 2 potentially conferring functional changes towards increased cell activation. Because KIR expression is influenced by maternal KIR haplotype, we next revisited our 6 findings ( Figure 1 ) that examined if differences in uNK activity exist between lean and obese women 7 by stratifying women into HBand HB + haplotypes. In non-stimulated conditions, the proportion of 8 CD107a + HB -uNK was not different between BMI groups [1.8% (obese) vs 2.1% (lean)]. However, 9
within HB + uNK, maternal obesity associated with higher proportions of CD107a + cells (6.7% vs 2.7%; 10 Figure 5a ). Following PMA stimulation, uNK from obese women of either haplotype degranulated at 11 higher frequencies (HB -: 8.2% vs 5.2%; HB + : 17.1% vs 8.2%), where HB + uNK cells from obese 12 women showed modestly higher degranulation rates than HBcells from obese women ( Figure 5b ). 13
Surprisingly, proportions of TNFα-expressing uNK were higher in PMA-primed HBcells from obese 14 women, where BMI-associated differences were not seen in HB + cells ( Figure 5c ). Consistent with our 15 previous results, maternal obesity did not affect proportions of IFNγ expressing uNK, regardless of 16 KIR haplotype ( Figure 5c ). 17 18 Obesity, combined with maternal HLA-C2 allotype, potentiates uNK activity 19 KIR expression can be affected by gestational age 39 and maternal HLA-C 40 . To determine if 20 KIR changes may relate to these BMI-independent variables, we next examined if gestational age and 21
maternal HLA-C affects 2DL1/S1 uNK proportions or expression levels. uNK 2DL1/S1 frequency and 22 expression level was comparable amongst different gestational ages (Supplementary Figure S3 ). 1 Homozygous C1/C1 subjects showed an inverse correlation in 2DS1 and 2DL1 frequency depending 2 on BMI. Specifically, uNK cells from obese C1/C1 women exhibited higher proportions of 2DS1 + cells 3 and lower proportions of 2DL1 + cells ( Supplementary Figure 4b ,c). Contrary to these KIR imbalances, 4
we also observed that the presence of maternal HLA-C2 associates with an increase in degranulation in 5 non-stimulated uNK from obese women (compared to C1/C1); this association was not maintained 6 following PMA stimulation (Figure 6a ,b). The impact of C2 allele on HB + cells was clear after PMA-7 priming ( Figure 6c ). However, HLA-C2-associated heightened activity did not translate into an 8 increase in PMA-stimulated cytokine production, although a modest trend was observed ( Figure 6d ). 9
These results demonstrate that in the context of obesity, maternal HLA-C2 allele equates to heightened 10 activity in HB + uNK. To examine if KIR2DL1/S1 alterations in obese/HB + uNK translate into functional changes, we 14 measured uNK responsiveness towards ectopically expressed HLA-C2 (Supplementary Figure S5a ). To 15 this end, HLA class I-deficient K562 cells stably expressing the HLA-Cw*0602 allele were subjected 16 to uNK activity/killing assays using KIR-genotyped uNK from lean and obese groups. HLA-Cw*0602 17 is the fourth most frequent HLA-C2 allele 41 and its specificity for 2DL1/S1 allowed us to minimize 18 confounding effects elicited by other HLA-C2-receptors (i.e. LILRB1, KIR2DL2/L3, and KIR2DS4) 42 . 19
To control for KIR-HLA-C2 interaction and to enable differentiation between 2DS1/2DL1-directed 20 responses against HLA-C2, CD107a surface mobilization in CD56 bright /KIRcells and HB -uNK were 21 compared to KIR + /HB + cells (Figure 7a and S5b). As expected, CD107a mobilization within 22 CD56 bright /KIR -uNK (HBand HB + ) in response to HLA-C2-expressing K562 cells was minimal 23 (Supplementary Figure S5b) . Similarly, HB -KIR + uNK (lacking 2DS1) from both BMI groups were 1 also minimally responsive towards HLA-C2 ( Figure 7b ). Importantly, 2DS1 + cells from HB + obese 2 women showed significantly higher CD107a mobilization than 2DS1 + cells from lean women in 3 response to high levels of HLA-C2 expression (4.2% vs 0.3%). While low-level HLA-C2 expression in 4 target cells showed a trend for increased degranulation in obese 2DS1-expressing uNK, this was not 5 significant. Together, these findings suggest that obesity alters the 2DL1/S1 balance in favour of 6 instructing an activating signal ( Figure 7b ). Interestingly, HB + uNK from obese C1/C1 women, which 7 have lower levels of 2DL1 and increased proportions of 2DS1 (Supplementary Figure S4b ,c), had 8 higher degranulation rates compared to HB + uNK from lean C1/C1 women after HLA-C2 stimulation 9
( Supplementary Figure 5c ). This suggests that the absence of a maternal HLA-C2 allele may affect 10 KIR2DS1/L1 responsiveness (education/licensing 43 ) to its cognate ligand. 11
Activation of KIR2DS1 strongly triggers cytolysis and cytokine production in pbNK, and this 12 engagement in cytotoxicity is more striking in the absence of KIR2DL1 44-46 . As our above finding 13
shows that HLA-C2 engagement enhances degranulation in HB + uNK from obese women, we next 14 examined whether HLA-C2 interactions also induce cytotoxicity. As expected, HLA-C2 interaction 15 with HB + uNK resulted in increased early apoptosis (measured by annexin V) of K562 target cells 16 compared to culture with HB -uNK cells (K562: 14.9% vs 9.8%; K-C2 Lo: 26.5% vs 14.2%; K-C2 Hi: 17
28.9% vs 16.0%); however we did not observe differences in late apoptosis based on KIR haplotype 18 ( Figure 7c,d) . Moreover, within HB + uNK, maternal obesity seemed to associate with impaired HLA-19 C2 instructed K562 killing, although low sample size/power prevented conclusive interpretation 20 (Figure 7c,d). To complement annexin V killing assays, we also analyzed whether secreted perforin 21 levels were different among lean and obese HB + subjects. In agreement with the annexin V results, the 22 levels of secreted perforin were comparable among BMI groups (Figure 7e ). However, obesity 23 appeared to dampen perforin secretion, suggesting that maternal obesity results in impaired uNK 1 cytotoxicity. To exclude the contribution of other KIR-expressing cells in HLA-C2 directed cytolysis, 2
we also analyzed proportions of T (CD3 + ) and NKT (CD56 + /CD3 + ) cells and their degranulation upon 3 HLA-C2 stimulation. We found the contribution of these cells on cytotoxicity was negligible 4 (Supplementary Figure S6) . These findings suggest that although HB + uNK cells from obese women 5
show enhanced HLA-C2 instructed activity (CD107a mobilization), this does not translate into 6 enhanced cytotoxicity. 7 8
Skewing of 2DS1 in lean and obese women results in dichotomous TNFα production 9
To investigate if the obesity-linked KIR2D-associated increase in uNK activity may also 10 translate into altered production of cytokines/angiokines important in pregnancy, we measured factors 11 from our cytokine 8-plex panel in conditioned media of HB + and HB -uNK from lean and obese women 12 stimulated with a KIR2DL1/S1 crosslinking/activating antibody (clone 11BP6). Changes in cytokine 13 secretion in uNK activated with 11BP6 were compared to responses from isotype-matched IgG1 14 antibody treatment within paired uNK cultures. As expected, 11BP6 treatment in HB + uNK led to 15 CD107a surface induction, whereas crosslinking did not lead to degranulation responses in HBcells; 16
these findings indicate that 11BP6 is only capable of inducing an activating response in uNK 17 expressing 2DS1 (Figure 8a ). Within lean HB + uNK, 11BP6 crosslinking resulted in an overall 18 decrease in TNFα; two 2DS1sp-containing uNK preparation responded to HLA-C2 by promoting 19
TNFα secretion ( Figure 8b ). As expected, secretion of TNFα in HB -uNK from either lean or obese 20 groups was not affected (Supplementary Figure 7a ). Additionally, we did not observe consistent 21 changes in PlGF, VEGF-A, VEGF-C, GM-CSF, IL10, IP10 or MIP1β following 2DL1/2DS1 22 crosslinking in uNK from lean HB +/women ( Figure 8b-d and S7 ). While a trending increase in GM-23 CSF production was observed in HB + uNK from obese women following crosslinking, penetrant and 1 consistent increases in TNFα production were observed (Figure 8b,d) . Notably, a significant interaction 2 between KIR2DL1/S1 crosslinking and BMI was identified, where 11BP6 had opposing effects on 3
TNFα production in uNK from lean and obese women ( Figure 8b ). Taken together, KIR2DL1/S1 4 crosslinking in uNK cultures from obese/HB + women promoted TNFα secretion and also appeared to 5 dampen the inhibitory effect of cytokine secretion (i.e. PlGF and TNFα) that was observed in lean HB + 6 cells. These data suggest that the uNK KIR2DL1/S1 imbalance in obese women, potentially favouring 7 2DS1 activity, differentially regulates HLA-C2-induced secretion of key factors important in vascular 8 remodeling. 9 10 11 DISCUSSION 1
In the present study we examined the effects of maternal obesity on uNK activity and function. 2
We show that maternal obesity links with heightened uNK activation/degranulation, and that this 3 change associates with differences in multiple NKRs known to play roles in uNK biology. Specifically, 4
we found that obesity correlates with reductions in NKp46 and NKG2A cell frequencies, while in HB + 5 obese women, exacerbated uNK activity is driven in part by an imbalance in activating KIR2DS1 and 6 inhibitory KIR2DL1 receptor expression. This altered obesity-related KIR2D phenotype, when 7 challenged with ectopic HLA-C2, led to a selective increase in TNFα production and the blunting in 8 inhibition of other key soluble factors. These findings highlight how the condition of obesity is able to 9 instruct functional changes in uNK and establishes insight into how uNK respond and/or adapt to an 10 obesogenic environment. 11
Our finding that maternal obesity associates with increased uNK activity is both novel and 12 complex. While uNK have a complete arsenal of lytic granules (perforin, granzyme A/B, granulysin), 13 their ability to mount cytotoxic responses against target cells is largely impaired compared to their 14 peripheral NK counterparts 32 . This difference is most likely due to the robust expression of inhibitory 15 NKRs (KIR2DL1, KIR2DL4, NKG2A, LILRB1) in uNK and a hampered ability for uNK to form 16 effective effector-target cell synapses 32 . Inhibitory NKRs facilitate uNK interaction with trophoblast 17 MHC-I antigen (i.e. HLA-C, HLA-E and HLA-G) to generate tolerogenic signals towards the fetus 47 . 18
Even though our work shows that obesity associates with enhanced uNK activity/degranulation and 19 links with altered NKR expression that might seemingly equate to increased cytotoxicity (i.e. decreases 20 in NKG2A & KIR2DL1; increase in KIR2DS1), these changes did not lead to enhanced K562 cell 21 killing. Instead, heightened uNK activity correlated with altered angiokine (increased PlGF, decreased 22 VEGF-A) and KIR2DS1/L1-instructed TNFα production. These findings indicate that although obesity 23 correlates with a shift towards activating NKRs in uNK, inhibitory mechanisms preserving immuno-1 tolerance/impaired cytotoxicity are largely maintained. Therefore the outcome of increased uNK 2 activity resulting from obesity most likely affects uterine vascular remodeling and angiogenesis. 3
Although our study does not examine this, prior studies showing impaired blood vessel remodeling in 4 rodents subjected to high-fat diets 24,25 and in obese pregnant women 23, 27 indicate that these vascular 5 defects may be the result of obesity-directed changes in uNK function. Further mechanistic work is 6 therefore required to decipher these interactions. 7
Our focus on KIR2D(L1/S1) stems from prior research showing the importance of these two 8 receptors in controlling aspects of placental development and in their associations with poor pregnancy 9 outcomes 11,35,48 . Notably, HLA-C2 directed activation of KIR2DS1 49 and the resulting expression of 10 GM-CSF in 2DS1sp uNK was shown to promote trophoblast invasion 35 . Moreover, a KIR2DS1 + 11 containing genotype (i.e. KIR B haplotype), in association with fetal HLA-C2 allotype, provides 12 protection from pregnancy disorders like recurrent miscarriage, preeclampsia, and intrauterine growth 13 restriction 36 . In contrast to this, a maternal KIR AA genotype (containing 2DL1, but not 2DS1) 14 combined with fetal HLA-C2 increases the risk of aberrant pregnancy outcome 36, 48 . Our finding that 15 maternal obesity associates with decreased proportions of 2DL1 + uNK and increased expression of 16 2DS1 in only KIR B haplotype (HB + ) women was somewhat perplexing due to obesity's predisposition 17 towards having a poor pregnancy outcome 23,50 . Our results indicate that, with respect to KIR2DL1/S1 18 composition, HB + uNK from obese women may actually be more capable of promoting healthy 19 placentation and may be protective against aberrant pregnancies. It may therefore be that HB + uNK 20 establish an active phenotype as a compensatory mechanism to facilitate successful placentation in 21 obesity. In contrast, HB -uNK (containing 2DL1, but not 2DS1), in the context of obesity, may show 22 aberrant/insufficient activation leading to compromised vascular remodeling and/or inadequate 23 placentation, and thus contribute to or potentiate poor outcomes in these women. Indeed, HB -uNK 1 from obese women were more efficient producers of TNFα following PMA stimulation and secreted 2 lower amounts of GM-CSF compared to HB -uNK from lean women, suggesting these cells may have 3 enhanced cytotoxic potential and/or an impaired ability to promote trophoblast invasion. 4
Comparison of cytokine/angiokine secretion profiles following KIR2DS1/L1 activation in HB + 5 uNK (2DL1 + /2DS1 + ) identified TNFα as a cytokine that is differentially regulated with respect to 6 KIR2DL1/S1 balance. Within the context of HB + lean women where 2DL1 + uNK proportions are 7 approximately 1.5-fold higher compared to HB + obese women, 2DL1/S1 activation results in decreased 8
TNFα production. In contrast, 2DL1/S1 activation with uNKs from obese women who have fewer 9 2DL1 + cells and also express higher levels of surface 2DS1 leads to an enhancement in, or at the very 10 least, the maintenance of TNFα production. These findings indicate that 2DL1 and 2DS1 play opposing 11 roles in controlling TNFα secretion, a finding that is consistent with previous work showing that 2DS1 12 engagement with HLA-C2 in CD8 + γδT cells induces TNFα 51 . Surprisingly, HLA-C2 interaction did 13 not potentiate an increase in CD107a expression over baseline levels observed in obese uNK exposed 14 HLA-C2-deficient target cells. This inconsistency could be explained by the presence of other 15 activating NKRs responding to target cell exposure (independent of HLA-C2). Moreover, our findings 16 also illustrate how environmental factors, such as obesity, can differentially modulate KIR2D receptor 17 activity following HLA-C interaction. Since factors that regulate KIR2DL1/S1 expression include prior 18 exposure to HLA-C and DNA methylation, and as changes in DNA methylation within 19 promoter/enhancer regions of genes have been associated with obesity 52 , it would be important to 20 examine if obesity regulates KIRs via epigenetic mechanisms. 21
In addition to KIR2DL1/S1 alterations, our findings also indicate that maternal obesity 22 associates with changes in other non-KIR NKRs that may play roles in modifying uNK function. 23
Specifically, we show that both inhibitory NKG2A and activating NKp46 expression levels and uNK 1 proportions are decreased in obesity. Within the uterine environment, NKG2A's primary ligand is 2 fetal/maternal derived HLA-E, and this interaction is thought to promote strong tolerogenic/inactivating 3 signals. Thus a loss or reduction in NKG2A signal may be a contributing factor in increased uNK 4 activity in obesity. Our observation of a bimodal distribution of NKp46 + uNK in obese women was 5 interesting, and was in stark contrast to the near ubiquitous nature of NKp46 in uNK from lean women. 6
Given that NKp46 is a member of the natural cytotoxicity receptor family and is directly involved in 7 target cell recognition and cytolysis 53 , our finding that NKp46 proportions and expression levels 8 decrease in obesity is contradictory to our finding that obesity also correlates with enhanced surface 9
CD107a/degranulation. However, in pbNK, lower surface levels of NKp46 associate with enhanced 10 activity and exposure to hCMV infection 54,55 . Other studies have shown that increases in NKp46 + NK 11
proportions align with enhanced cytotoxicity 56 . 12
How NKp46 modifications in obese uNK contribute to overall activity and function at this point 13 is unclear. It is tempting to speculate that the combined decrease in NKG2A in uNK may translate to 14 enhanced NKp46 function, a relationship that has been previously identified 56 and PlGF 30,58 , a finding somewhat consistent with our observation that uNK from obese women secrete 20 less VEGF-A, albeit higher amounts of PlGF. It is possible that this VEGF-A/PlGF imbalance may 21 instruct a shift from PlGF/VEGF-coordinated angiogenesis to aberrant pro-inflammatory signals that 22 are characteristic of conditions associated with of elevated levels of PlGF 59 and which have been 23 reported to coincide with early pregnancy loss 59 . Therefore it seems possible that uterine vascular 1 defects and altered angiokine profiles seen in obese women may in part be the result of altered NKp46 2 activity. 3
uNK are specialized cells that are thought to play essential roles in coordinating and controlling 4 critical processes in pregnancy. While uNK bear some similarities to cytotoxic pbNK counterparts (i.e. 5 contain cytolytic granules), their primary role does not appear to involve the induction of cell-mediated 6
killing. While our study provides evidence that changes within the maternal environment resulting from 7 obesity lead to profound phenotypic and functional differences in uNK, these changes appear to impact 8 predominately angiogenic pathways and do not instruct heightened killing activity. Moving forward, it 9
will be important to examine how the condition of obesity instructs altered uNK function. Identification 10 of obesity-enriched or depleted factors within the maternal-fetal interface that contribute to uNK 11 dysregulation will be important in generating an understanding into the etiology of obesity-related 12 pregnancy disorders. 13 14 15 METHODS 1
Patient recruitment and tissue collection 2
Informed written consent was obtained from women (19 to 35 years of age) that were 3 undergoing elective pregnancy termination at British Columbia's Women's Hospital, Vancouver, 4
Canada. This study was conducted with approval from the Research Ethics Board on the use of human 5 subjects, University of British Columbia (H13-00640). Fresh first trimester decidual tissues (5 to 12 6 weeks of gestation) and whole blood (N = 184) were collected from participating women having 7 confirmed viable pregnancies indicated by ultrasound-measured fetal heartbeat. Decidual tissue 8 samples were selected based on the presence of a smooth uterine epithelial layer and a course/textured 9 thick spongy underlayer. Patient clinical characteristics i.e. height and weight were additionally 10 obtained to calculate body mass index (BMI: kg/m 2 ). Samples were classified as lean (BMI 20-24.9 11 kg/m 2 ; n = 104) or obese (BMI ≥30 kg/m 2 ; n = 80). Further information regarding the studied cohorts is 12 depicted in Table 1 . For the discrimination of KIR2DS1 and KIR2DL1 cell subsets, cells were stained for 15 minutes 19 at RT with 10 µl of KIR2DL1. Then, cells were staining with the rest of the markers including 20 KIR2DL1/S1 antibody for 20 minutes at 4°C. Traditional flow cytometry gating strategies for assessing 21 of KIR2DL1/S1 populations gated on CD56 bright (total) uNK cells, but in this study we gated on 22 CD56 bright /KIR + cells. The advantage of our strategy allows recognition of subjects carrying the 23 KIR2DL3*005 allele, which would be wrongly identified as a KIR2DS1sp subset (Supplementary 1 Figure S8a ) due to non-specific binding of monoclonal KIR2DL1/S1 antibodies (clones EB6B and 2 11PB6) 60 . Analysis of our data using the conventional gating strategy showed no differences 3 (Supplementary Figure S8b) with the results obtained for gated KIR + uNK (Figure 4e ). 4 5
Gene expression analysis 6
Prior to RNA extraction, uNK were enriched using a negative selection exclusion strategy using 7 immuno-labeled magnetic beads cocktails following the manufacturers protocol (EasySep Human NK 8 cell Enrichment Kit; StemCell Technology). Total RNA was prepared from magnetic-bead enriched 9 uNK cells using the RNAqueous Total RNA Isolation Kit following the manufacturer's instructions 10 (Ambion, Austin, TX). RNA purity was confirmed using a NanoDrop Spectrophotometer (Thermo 11
Fisher Scientific). One microgram of RNA was reverse-transcribed using a first-strand cDNA synthesis 12 kit (QuantaBiosciences Inc., Gaithersburg, MD) and subjected to qPCR (∆∆CT) analysis, using 13
TaqMan Universal Master Mix II (Life Technologies, Waltham, MA) on an ABI 7500 Sequence 14
Detection System (Life Technologies). Primer sets and Taqman MGB probes (6FAM 5'-3' MGBNFQ) 15
used for qPCR analysis were as follow: 2DL1F: 5'-GCAGCACCATGTCGCTCT-3'; 2DL1R: 5'-16
GTCACTGGGAGCTGACAC-3';
Probe: 5-ATGCTGACGAACAAGAG-3'; 2DS1F: 5'-17
TCTCCATCAGTCGCATGA-3';
2DS1R: 5'-AGGGCCCAGAGGAAAGTT-3'; Probe: 5'-18
AGGTCTATATGAGAAACC-3':
2DS3F; 5'-TCACTCCCCCCTATCAGTTT-3'; 2DS3R; 5'-19
GCATCTCTAGGTTCCTCCT-3';
Probe: 5'-GCCCCACGGTTCT-3'; 2DS5F; 5'-20 GCTCATGGTCATCAGCATGG-3'; 2DS5R; 5'-CGACCGATGGAGAAGTTGC-3'; Probe: 5'-21
CACATGAGGGATTCC. ACTB (β-actin) FAM (Hs99999903_m1) from Thermo Fisher. Gene 22
expression was normalized to β-actin levels. 23 1 Genetic typing of KIR2DS1 and HLA-C1/2 2 Genomic DNA was extracted from peripheral blood mononuclear cells (PBMCs) by DNeasy Blood kit 3 (QIAGEN, Hilden, Germany). PCR amplification was performed using KIR specific sequence primers 4 48 to identify the presence or absence of KIR2DS1 and KIR2DL1 genes ( Supplementary Table 3 ). HLA-5 C genes were allotype as either C1 or C2 using sequence specific nucleotides primers as described in 61 6 and KIR and HLA-C genotypes were assigned ( Supplementary Table 1,3) . 
Functional assays 20
An enriched decidual uNK cell fraction was used for all functional assays (> 60% uNK). 21
Degranulation/activity assays were assessed by flow cytometry as described previously 27 . 22
Briefly, 1x10 6 uNK were cultured alone (non-stimulated), primed with 10 ng/ml PMA, and 500 ng/ml 23 ionomycin, or in co-culture with 2x10 5 K562 target cells (Effector:Target ratio of 5:1). Next, brefeldin 1 A at 3 µg/ml and monensin at 10 µg/ml from Thermo Fisher were added for the last 3 hours. Uterine 2 NK cells then were stained following the same procedure described in the flow cytometry section. At 3 least 20,000 events were collected in the stopping gate (CD3 -FVD780 -CD45 + CD56 bright cells). 4
Apoptosis Annexin V/FVD780 assay was performed using Annexin V-PeCy7 antibody (Thermo 5
Fisher Scientific). Culture conditions were the same as described for the K562 target cell degranulation 6 assay (ratio 5:1), without the addition of brefeldin A or monensin. After 4 hours of co-culture, decidual 7 leukocytes and K562 target cells stained for FVD780 and CD45-ef450 for 30 minutes at 4°C. 8
Following washes with Binding Buffer (Thermo Fisher Scientific), cells were stained for Annexin V 9
for 10 minutes at RT, washed in in 200 µl of Binding Buffer 1X, and data was acquired on an LSRII 10 FACS (BD Biosciences); at least 20,000 events were collected. 11
Perforin ELISA. Cell culture supernatants were harvested after 4 hours of decidual leukocyte 12 co-culture with K562 target cells, centrifuged, and snap frozen in liquid nitrogen. Secreted perforin 13 measurements were conducted using Human Perforin ELISA kit (Origene, Rockville, MD, USA) 14 following manufacturer's instructions. ELISA plates were read using a FLUOstar Optima plate reader 15 (BMG LabTech). 16
17
Multiplex cytokine/angiokine/chemokine array 18
Decidual leukocytes (DL; > 60% uNK) stimulated by KIR2DL1/S1 receptor ligation using 19
antibody-coated V-bottom 96-well plates (Corning, NY, USA). KIR2DL1/S1 antibody (clone 11PB6; 20
Miltenyi Biotec, Bergisch Gladbach, Germany) or IgG1 (Thermo Fisher) were coated at a 21 concentration of 2.5 µg/ml in 50 mM HEPES buffer at 4°C overnight. Following antibody coating, 22 wells were washed three-times with PBS and 5x10 5 DL were seeded in RPMI1640 medium containing 23 10% FBS, 1 mM sodium pyruvate (Life Technologies), 55 nM βME (Sigma), 1% 1 penicillin/streptomycin (Life Technologies), and 1% anti antimycotic (Life Technologies) at 37°C 5% 2 CO 2 . After 4 hours, cell supernatants were collected and analyzed for secreted factors using a custom 28.36 23 to 33 P = 0.32 8.5 7.1 to 9.6 P = 0.003 34.56 31.62 to 37.04 P < 0.0001 cytometry gating strategy for KIR2DL1/S1 analysis. CD3/FVD780 exclusion identifies live CD3cells 2 that are further selected on CD45, CD56, and KIR2D(L1/S1/S3/S5) positivity. Within the KIR + 3 population, uNK are analyzed for KIR2DS1 and KIR2DL1 expression using antibodies directed against 4 KIR2DL1 and KIR2DS1/L1 where three subsets (KIR2DS1sp, KIR2DL1/S1dp, KIR2DL1sp; sp, 5 single-positive; dp, double-positive) are identified. Int P = 0.50 BMI P = 0.83 Ab P = 0.84
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